Another problem is that patients do not always follow their treatment regimens
If youre curious whether a GLP-1 medication might be appropriate for your situation, the most productive first step is a conversation with your endocrinologist particularly one familiar with off-label use and experienced in adjusting insulin regimens in response
Whats the most common side effect of retatrutide
Cardioprotective effects of glucagon-like peptide 1 receptor agonists in heart failure: myth or truth
Taylor SI, Blau JE, Rother KI, Beitelshees AL (2019) SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks
Compared to obese mice treated with Veh, KPCY and LLC tumors in mice treated with RETA failed to engraft 33-50% of the time and did not grow appreciably, which suggests that RETA may impact both cancer risk and progression